ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,556, issued on May 19, was assigned to Dart NeuroScience LLC (Dallas).
"Substituted [1,2,4triazolo[1,5-apyrimidin-7-yl compounds as PDE2 inhibitors" was invented by James Breitenbucher (Escondido, Calif.), Graeme Freestone (San Diego), Laurent Gomez (San Diego), Robert Lemus (Escondido, Calif.), Kiev Ly (San Diego), Margaret McCarrick (San Diego), William Vernier (Vista, Calif.) and Troy Vickers (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a chemical entity of Formula (I):wherein R1, R2, X, Y and Z have any of the values described herein, and compositions comprising such chemical entities; methods of making them; a...